![]() |
Figure 7: Ta1 prolongs survival in stage IV melanoma. In a European study with 488 subjects, addition of Ta1 to DTIC chemotherapy led to a statistically significant improvement in overall survival, especially in patients with normal lactate dehydrogenase (LDH) levels [167]. |